Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: A descriptive study on clinical features and myopathology

Arthritis Research and Therapy

Volumn 16, Issue 3, 2014, Pages

  Bhansing, Kavish J ^a   Lammens, Martin ^b   Knaapen, Hanneke K A ^a   van Riel, Piet L C M ^a   van Engelen, Baziel G M ^a   Vonk, Madelon C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBON MONOXIDE; CENTROMERE ANTIBODY; ENZYME ANTIBODY; TOPOISOMERASE 1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTHRITIS; ARTICLE; ASPIRATION PNEUMONIA; BASAL CELL CARCINOMA; BREAST CANCER; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CELL VACUOLE; CLINICAL FEATURE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIASTOLIC DYSFUNCTION; DISEASE DURATION; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IDIOPATHIC POLYMYOSITIS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; KIDNEY CARCINOMA; LUNG CARCINOMA; LUNG FIBROSIS; LUNG TRANSFER FACTOR; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUSCLE BIOPSY; MUSCLE CELL; NEUROLOGIST; NEUROPATHOLOGIST; NEUROPATHOLOGY; PATHOLOGIST; POLYMYOSITIS; PREVALENCE; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RESPIRATORY FAILURE; SCLERODERMA; SCLERODERMA POLYMYOSITIS; SEROLOGY; SEX RATIO; SYSTEMIC SCLEROSIS; TOTAL LUNG CAPACITY; AGED; ANALYSIS OF VARIANCE; BIOPSY; MIDDLE AGED; MUSCLE; MUSCLE DISEASE; MYOSITIS; NECROSIS; PATHOLOGY; PROSPECTIVE STUDY; SYNDROME;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLES; MUSCULAR DISEASES; MYOSITIS; NECROSIS; POLYMYOSITIS; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SYNDROME;

EID: 84901693039     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4562     Document Type: Article

References (31)

1. Furst DE, Clements PJ. Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol Suppl 1997, 48:53-57.
2. Medsger TA, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971, 74:714-721. 10.7326/0003-4819-74-5-714, 5559436.
3. Medsger TA, Rodnan GP, Moossy J, Vester JW. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1968, 11:554-568. 10.1002/art.1780110405, 5676926.
4. Thompson JM, Bluestone R, Bywaters EG, Dorling J, Johnson M. Skeletal muscle involvement in systemic sclerosis. Ann Rheum Dis 1969, 28:281-288. 10.1136/ard.28.3.281, 1031178, 18623879.
5. Tuffanelli DL. Scleroderma and its relationship to the " collagenoses" : dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Am J Med Sci 1962, 243:133-146.
6. Clements PJ, Furst DE, Campion DS, Bohan A, Harris R, Levy J, Paulus HE. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 1978, 21:62-71. 10.1002/art.1780210111, 623695.
7. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol 2005, 24:99-102. 10.1007/s10067-004-0975-7, 15322944.
8. Ranque B, Authier FJ, Le-Guern V, Pagnoux C, Berezne A, Allanore Y, Launay D, Hachulla E, Kahan A, Cabane J, Gherardi R, Guillevin L, Mouthon L. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis 2008, 68:1474-1477.
9. Follansbee WP, Zerbe TR, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993, 125:194-203. 10.1016/0002-8703(93)90075-K, 8417518.
10. Tuffanelli DL, Winkelmann RK. Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol 1961, 84:359-371. 10.1001/archderm.1961.01580150005001, 13778561.
11. Mimori T. Scleroderma-polymyositis overlap syndrome: clinical and serologic aspects. Int J Dermatol 1987, 26:419-425. 10.1111/j.1365-4362.1987.tb00580.x, 3308722.
12. Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, Tohma S, Endo H, Hirohata S. Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 2011, 38:1931-1939. 10.3899/jrheum.100298, 21765111.
13. van Engelen BG, van Veenendaal H, van Doorn PA, Faber CG, van der Hoeven JH, Janssen NG, Notermans NC, van Schaik IN, Visser LH, Verschuuren JJ. The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromusc Disord 2007, 17:33-37. 10.1016/j.nmd.2006.09.017, 17141501.
14. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheumatism 1980, 23:581-590. 10.1002/art.1780230510, 7378088, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
15. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347. 10.1056/NEJM197502132920706, 1090839.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403-407. 10.1056/NEJM197502202920807, 1089199.
18. van der Pas J, Hengstman GJ, Ter Laak HJ, Borm GF, van Engelen BG. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004, 75:136-139. 1757482, 14707323.
19. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986, 314:329-334. 10.1056/NEJM198602063140601, 3945256.
20. Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Gulati S, Handa R. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis. Acta Neurol Scand 2011, 123:122-129. 10.1111/j.1600-0404.2010.01353.x, 20497129.
21. Dalakas MC. Sporadic inclusion body myositis: diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006, 2:437-447. 10.1038/ncpneuro0261, 16932602.
22. Ranque B, Berezne A, Le-Guern V, Pagnoux C, Allanore Y, Launay D, Hachulla E, Authier FJ, Gherardi R, Kahan A, Cabane J, Guillevin L, Mouthon L. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010, 39:498-505. 10.3109/03009741003774626, 20726682.
23. West SG, Killian PJ, Lawless OJ. Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum 1981, 24:662-668. 10.1002/art.1780240506, 7236323.
24. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissay JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009, 53:1475-1487. 10.1016/j.jacc.2009.02.007, 2743893, 19389557.
25. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010, 69:1809-1815. 10.1136/ard.2009.114264, 20551155.
26. Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl: Clinical and immunogenetic associations. Arthritis Rheum 1992, 35:1211-1217. 10.1002/art.1780351014, 1418007.
27. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 1981, 68:611-620. 10.1172/JCI110295, 370841, 7276162.
28. Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA. Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum 2009, 60:1112-1118. 10.1002/art.24409, 19333934.
29. Kaji K, Fertig N, Medsger TA, Satoh T, Hoshino K, Hamaguchi Y, Hasewaga M, Lucas M, Schnure A, Ogawa F, Sato S, Takehara K, Fuijmoto M, Kuwana M. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res (Hoboken) 2014, 66:575-584. 10.1002/acr.22163, 24023044.
30. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004, 14:337-345. 10.1016/j.nmd.2004.02.006, 15099594.
31. Varadhachary AS, Weihl CC, Pestronk A. Mitochondrial pathology in immune and inflammatory myopathies. Curr Opin Rheumatol 2010, 22:651-657. 10.1097/BOR.0b013e32833f108a, 20827203.